Invention Grant
- Patent Title: β-lactamase inhibitors
-
Application No.: US16305414Application Date: 2017-06-02
-
Publication No.: US10738051B2Publication Date: 2020-08-11
- Inventor: Boyu Hu , Charles Z. Ding , Zhigang Huang , Ruibin Lin , Minliang Xiao , Jinsheng Xie , Shuhui Chen , Cheng Li
- Applicant: QILU PHARMACEUTICAL CO., LTD.
- Applicant Address: CN Jinan, Shandong
- Assignee: QILU PHARMACEUTICAL CO., LTD.
- Current Assignee: QILU PHARMACEUTICAL CO., LTD.
- Current Assignee Address: CN Jinan, Shandong
- Agency: Harness, Dickey & Pierce, P.L.C.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@2cc1f2dc
- International Application: PCT/CN2017/086999 WO 20170602
- International Announcement: WO2017/206947 WO 20171207
- Main IPC: C07D471/08
- IPC: C07D471/08 ; A61P31/04
Abstract:
Disclosed in the present invention is a type of novel β-lactamase inhibitors, and specifically disclosed are a compound represented by formula (I) or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20200010467A1 NOVEL BETA-LACTAMASE INHIBITORS Public/Granted day:2020-01-09
Information query
